Levoxyl and Vivelle-dot drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Levoxyl (levothyroxine sodium) and Vivelle-dot (estradiol). Common drug interactions include arthritis among females.

The phase IV clinical study analyzes what interactions people have when they take Levoxyl and Vivelle-dot. It is created by eHealthMe based on reports of 58 people who take the same drugs from the FDA, and is updated regularly.

What is Levoxyl?

Levoxyl has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. eHealthMe is studying from 25,178 Levoxyl users. Check the latest studies of Levoxyl.

What is Vivelle-dot?

Vivelle-dot has active ingredients of estradiol. It is often used in hormone replacement therapy. eHealthMe is studying from 3,545 Vivelle-dot users. Check the latest studies of Vivelle-dot.



On Jul, 14, 2026

58 people who take Levoxyl and Vivelle-dot together, and have interactions are studied.

Levoxyl and Vivelle-dot drug interactions.

What are the common drug interactions of Levoxyl and Vivelle-Dot, by gender? *:

female:

  1. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  2. Breast cancer
  3. Fatigue (feeling of tiredness)
  4. Memory impairment
  5. Abdominal distension
  6. Anger
  7. Bruxism (habitual grinding of the teeth, typically during sleep)
  8. Crying
  9. Decreased activity
  10. Dizziness

male:

n/a

What are the common drug interactions of Levoxyl and Vivelle-Dot, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Cough
  2. Fatigue (feeling of tiredness)
  3. Pain
  4. Upper-airway cough syndrome
  5. Adrenocortical insufficiency acute (suddenly adrenal glands do not produce adequate amounts of steroid hormones)

40-49:

  1. Muscle spasms (muscle contraction)
  2. Neck pain
  3. Rash
  4. Sinusitis (inflammation of sinus)

50-59:

  1. Myalgia (muscle pain)
  2. Nausea (feeling of having an urge to vomit)
  3. Pain
  4. Pyrexia (fever)
  5. Reverse tri-iodothyronine increased
  6. Stress
  7. Weight decreased
  8. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  9. Breast cancer
  10. Memory impairment

60+:

  1. Drug ineffective
  2. Fatigue (feeling of tiredness)
  3. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  4. Asthenia (weakness)
  5. Asthma
  6. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  7. Back injury
  8. Blood pressure fluctuation
  9. Breast adenoma (breast tumour)
  10. Breast calcifications (deposits of calcium that can be seen on a mammogram of the breast)

What are the existing conditions these people have? *

  1. High Blood Pressure: 23 people, 39.66%
  2. Hot Flush (sudden feelings of heat): 21 people, 36.21%
  3. Depression: 21 people, 36.21%
  4. Menopause (end of monthly cycles in women): 18 people, 31.03%
  5. Back Pain: 15 people, 25.86%
  6. High Blood Cholesterol: 12 people, 20.69%
  7. Irritable Bowel Syndrome: 10 people, 17.24%
  8. Menopausal Symptoms: 8 people, 13.79%
  9. Breast Cancer: 8 people, 13.79%
  10. Cough: 4 people, 6.90%

* Approximation only. Some reports may have incomplete information.

Do you take Levoxyl and Vivelle-dot?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Levoxyl and Vivelle-dot:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Levoxyl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Vivelle-dot:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Levoxyl and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vivelle-dot and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on levothyroxine sodium and estradiol (the active ingredients of Levoxyl and Vivelle-dot, respectively), and Levoxyl and Vivelle-dot (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: